The anti-diabetic ayurvedic drug BGR-34 has been jointly developed by National Botanical Research Institute and Central Institute for Medicinal and Aromatic Plants. It has been economically priced at 5 rupees per tablet as compared to latest DPP4 inhibitors globally.